I misunderstand nothing TV, you appear to know little about the commercial aspects of Bio's.
ADO should have received big upfront payments for even allowing Phillips/BBI to use ADO's products to improve their POC devices.
A long time ago I was invested in a small Bio which received a $20m upfront payment for allowing a big pharma to even get their hands on the small Bio's patented product. That was before they'd even tried to use it.
IMO ADO have already missed out. The more I read about Phillips the less I like them.
as for Sojourner et.al. they know nothing.
no more on ADO from me today.
just stick to the facts, page-15
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
-0.002(8.33%) |
Mkt cap ! $54.31M | |||
| Open | High | Low | Value | Volume |
| 2.4¢ | 2.4¢ | 2.2¢ | $12.59K | 542.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 487271 | 2.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.3¢ | 200000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| ADO (ASX) Chart |